Abstract
Reviews of the safety of intrauterine contraception usually are based on studies that do not reflect changes in clinical practice that have occurred over time, and that include many types of IUDs that are no longer used. Studies of insertions of the Multiload 375 and Copper T 380 performed since 1980, which more accurately reflect current clinical practice, show that these IUDs provide a high level of protection against pregnancy and are associated with low rates of complications. Current clinical opinion regarding the safety of IUDs needs to be reassessed in light of the positive safety record of these IUDs.
Resumé
Les études portant sur la sáreté de la contraception intra-utérine sont en général fondées sur des études ne reflètant pas les changements dans les pratiques cliniques intervenus au cours des années et se rapportent à de nombreux types de DIU qui ne sont plus utilisés. Les études concernant les insertions de Multiload 375 et Copper T 380 effectuées depuis 1980, qui d'ailleurs reflètent mieux la pratique clinique actuelle, indiquent que ces DIU offrent un haut niveau de protection contre les grossesses et qu'ils sont associés à de faibles pourcentages de complications. S'agissant de la sûreté des DIU, il y a lieu de réévaluer l'opinion clinique actuelle à la lumière des résultats positifs obtenus avec ces dispositifs dans ce domaine.
Resumen
Los estudios relativos a la seguridad de la anticoncepción intrauterina suelen basarse en estudios que no reflejan los cambios en las prácticas clínicas ocurridos con el correr del tiempo y que incluyen muchos tipos de DIU que ya no se utilizan. Los estudios relativos a las inserciones del Multiload 375 y Copper T 380 realizados después de 1980, y que reflejan mejor la práctica clínica actual, indican que estos DIU ofrecen un alto nivel de protección contra los embarazos y están asociados con bajos porcentajes de complicationes. En lo que respecta a la seguirdad de los DIU, es necesario evaluar nuevamente la opinión clínica actual a la luz de los resultados positivos obtenidos con estos dispositivos.
Similar content being viewed by others
References
World Health Organization. Mechanism of action, safety, and efficacy of intrauterine devices. Technical Report Series 753. World Health Organization, 1987.
Cates W, Grimes DA, Ory HW, Tyler CW. Publicity and the public health: the elimination of IUD-related abortion deaths. Fam Plann Perspect. 1977;9:138–40.
Pollack AE, Girvin S. When should an IUD be removed and replaced? Med Aspects Hum Sex. 1991;26(2):46–58.
Edelman DA, Berger GS, Keith L. The use of IUDs and their relationship to pelvic inflammatory disease: a review of epidemiologic and clinical studies. Curr Probl Obstet Gynecol. 1982;6(3):1–62.
Grimes DA. Intrauterine devices and pelvic inflammatory disease; recent developments. Contraception. 1987;36:97–109.
Timonen H, Nylander P, Kivijarvi A et al. Comparative performance of three copper IUDs (MLCu375, Fincoid, Nova-T) after one-year's follow-up in randomized multicenter trial. Contracept Deliv Syst. 1982;3(3/4): Abstract 226.
Thiery M, Van der Pas H, Van Kets H. The MLCu375 intrauterine contraceptive device. Adv Contracept. 1985;1:37–44.
Cole LP, Potts DM, Aranda C et al. An evaluation of the TCu 380Ag and the Multiload Cu375. Fertil Steril. 1985;43:214–7.
de Castro P, Perez-Inglesias R, Vicandi F et al. Comparison of two copper IUDs: the MLCu375 and the Nova-T. Adv Contracept. 1987;3:319–22.
Bratt H, Skjeldestad FG, Valentin KC. A randomized trial of three copper IUDs (MLCu250, MLCu375 and Nova T). Acta Obstet Gynecol Scand. 1988;67:247–51.
Lovset T. A comparative evaluation of the Multiload 250 and Multiload 375 intra-uterine devices. Acta Obstet Gynecol Scand. 1990;69:521–6.
Husain FA, Kazi A, Khan T. Clinical study of Multiload Cu375 in Pakistan. Adv Contracept. 1991;7:281–6.
Sastrawinata S, Farr G, Prihadi SM et al. A comparative clinical trial of the TCu 380A, Lippes Loop D and Multiload 375 IUDs in Indonesia. Contraception. 1991;44:141–54.
Ho J, Wu Z, Cai S et al. A randomized comparative trial of the MLCu375, TCu220C, Steel Ring and uterine Cavity-Shaped IUDs. Adv Contracept. 1992;8:161–6.
Cole LP, Potts DM, Aranda C et al. Comparative copper IUD trials. In: Zatuchni GI, Goldsmith A, Sciarra JJ, eds. Intrauterine Contraception: Advances and Future Prospects. Harper & Row. 1985:95–100.
World Health Organization. The TCu380A, Multiload 250 and Nova T IUDs at 3, 5, and 7 years of use — results from three randomized multicentre trials. Contraception. 1990;42:141–58.
Sivin I, Mahgoub El S, McCarthy T et al. Long-term contraception with the levonorgestrel 20 μg/day (LNg 20) and Copper T 380Ag intrauterine devices: a five-year randomized study. Contraception. 1990;42:361–78.
Sivin I, Shaaban M, Odlind V et al. A randomized trial of the Gyne T 380 and Gyne T Slimline intrauterine copper devices. Contraception. 1990;42:379–89.
Norplant System. Physicians Desk Reference, 1992 ed. Medical Economics Data. Montvale, NJ. pp 2424–8.
Saure A, Hirvonen E, Kivijarvi A, Timonen H. Comparative performance of Fincoid, Nova-T, ML 375 IUDs. In: Zatuchni GI, Goldsmith A, Sciarra JJ, eds. Intrauterine Contraception: Advances and Future Prospects. Harper & Row. 1985:104–8.
Sung S, Qian L-J, Liu X. Two-year comparative clinical experience with three IUDs in China. In: Zatuchni GI, Goldsmith A, Sciarra JJ, eds. Intrauterine Contraception: Advances and Future Prospects. Harper & Row. 1985:109–14.
Indian Council of Medical Research Task Force on IUD. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Contraception. 1989;39:37–52.
Edelman DA, Berger GS, Keith L. Intrauterine devices and their complications. GK Hall & Co., 1979.
Khomassuridze AG, Tsertsvadze GL, Kavkasidze GA. Two years of experience with the Multiload Cu375 in Georgia. Adv Contracept. 1991;7:287–90.
Wilson JC. A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375 and MLAgCu250): 1-, 2- and 3-year results. Adv Contracept. 1992;8:153–9.
Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980;138:880–92.
Sandmire HF. Fertility after intrauterine device discontinuation. Adv Contracept. 1986;2:327–35.
Belhadj H, Sivin I, Diaz S et al. Recovery of fertility after, use of the levonorgestrel 20mcg/day or copper T 380 Ag intrauterine device. Contraception. 1986;34:261–7.
Skjeldestad EE, Bratt H. Return of fertility after use of IUDs (Nova T, MLCu250 and MLCu375). Adv Contracept. 1987;3:139–47.
Van Kets HE, Thiery M, Van der Pas H, Dieben TOM. Long-term experience with Multiload intrauterine devices. Adv Contracept. 1989;5:179–88.
Wilson JC. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study. Am J Obstet Gynecol. 1989;160:391–6.
Farley TM, Rosenberg MJ, Rowe PJ et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339:785–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edelman, D.A., Porter, C.W. The new intrauterine contraceptive devices: Safe and effective. Adv Contracept 9, 83–91 (1993). https://doi.org/10.1007/BF02115905
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02115905